Life Sciences and Diagnostics Lifts Danaher Q4 Revenues 6 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Danaher today said that revenues in the fourth quarter rose nearly 6 percent year over year paced by its Life Sciences and Diagnostics segment.

For the three months ended Dec. 31, 2012, the company posted total revenues of $4.98 billion, up from $4.72 billion in the year-ago period, and beating the consensus Wall Street estimate of $4.81 billion.

Core revenues increased 3.5 percent year over year during the quarter, while acquisitions added 3 percent growth, and the impact of currency translation cut growth by 1 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.